JPWO2019224602A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019224602A5
JPWO2019224602A5 JP2021515298A JP2021515298A JPWO2019224602A5 JP WO2019224602 A5 JPWO2019224602 A5 JP WO2019224602A5 JP 2021515298 A JP2021515298 A JP 2021515298A JP 2021515298 A JP2021515298 A JP 2021515298A JP WO2019224602 A5 JPWO2019224602 A5 JP WO2019224602A5
Authority
JP
Japan
Prior art keywords
group
pharmaceutical composition
composition according
compound
alkenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021515298A
Other languages
English (en)
Japanese (ja)
Other versions
JP7508447B2 (ja
JP2021526552A5 (https=
JP2021526552A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2019/000655 external-priority patent/WO2019224602A2/en
Publication of JP2021526552A publication Critical patent/JP2021526552A/ja
Publication of JPWO2019224602A5 publication Critical patent/JPWO2019224602A5/ja
Publication of JP2021526552A5 publication Critical patent/JP2021526552A5/ja
Application granted granted Critical
Publication of JP7508447B2 publication Critical patent/JP7508447B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021515298A 2018-05-23 2019-05-22 血糖制御を改善し、炎症性腸疾患を処置するための構造修飾脂肪酸 Active JP7508447B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NO20180714 2018-05-23
NO20180714 2018-05-23
PCT/IB2019/000655 WO2019224602A2 (en) 2018-05-23 2019-05-22 Structurally modified fatty acids for improving glycemic control and treating inflammatory bowel disease

Publications (4)

Publication Number Publication Date
JP2021526552A JP2021526552A (ja) 2021-10-07
JPWO2019224602A5 true JPWO2019224602A5 (https=) 2022-05-30
JP2021526552A5 JP2021526552A5 (https=) 2022-05-30
JP7508447B2 JP7508447B2 (ja) 2024-07-01

Family

ID=67688797

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021515298A Active JP7508447B2 (ja) 2018-05-23 2019-05-22 血糖制御を改善し、炎症性腸疾患を処置するための構造修飾脂肪酸

Country Status (8)

Country Link
US (2) US20210290576A1 (https=)
EP (1) EP3796901A2 (https=)
JP (1) JP7508447B2 (https=)
KR (2) KR20250150676A (https=)
CN (1) CN112351775A (https=)
AU (1) AU2019274203B2 (https=)
CA (1) CA3101041A1 (https=)
WO (1) WO2019224602A2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102760537B1 (ko) 2022-01-20 2025-02-03 한국과학기술연구원 삼원계 광활성층 조성물 및 이를 포함하는 유기태양전지

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5620272B2 (ja) 2007-11-09 2014-11-05 プロノヴァ・バイオファーマ・ノルゲ・アーエスPronova BioPharma NorgeAS 化粧品において,食品サプリメントとして,または医薬品として用いるための脂質化合物
EP2147910A1 (en) * 2008-07-15 2010-01-27 Pronova BioPharma Norge AS Novel lipid compounds
SG175401A1 (en) * 2009-05-08 2011-12-29 Pronova Biopharma Norge As Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
JP2013517322A (ja) 2010-01-20 2013-05-16 プロノヴァ・バイオファーマ・ノルゲ・アーエス サリチレート脂肪酸誘導体
CA3070513C (en) * 2010-05-05 2023-01-03 Boehringer Ingelheim International Gmbh A dpp-4 inhibitor for use in treatment of skin-alterations or necrosis
PL2961727T3 (pl) 2013-02-28 2017-06-30 Pronova Biopharma Norge As Sposób wytwarzania kwasu 2-((5Z,8Z, 11Z,14Z,17Z)-ejkoza-5,8,11,14,17-pentaenyloksy)butanowego
US20180110747A1 (en) 2015-04-01 2018-04-26 Pronova Biopharma Norge As Use of thia oxo compounds for lowering apo c3
BR112017023164A2 (en) * 2015-04-28 2018-07-24 Pronova Biopharma Norge As and method of preventing and / or treating non-alcoholic steatohepatitis in an individual in need thereof

Similar Documents

Publication Publication Date Title
JP2011528350A5 (https=)
US12129247B2 (en) Administration regime for nitrocatechols
JP2021526133A5 (https=)
JP2009530398A5 (https=)
JP2008543854A5 (https=)
US20240166613A1 (en) Proxisome proliferator activated receptor (ppar) compounds and methods of using the same
JP2007523155A5 (https=)
JP2004531543A5 (https=)
JP2019524747A (ja) 痛風または高尿酸血症に関連する症状を処置または予防するための化合物、組成物、および方法
JP2011527345A5 (https=)
JP4553166B2 (ja) ニコチン酸エステルおよびそれを含む薬剤組成物
JP2015519322A5 (https=)
JP2020111571A5 (https=)
RU2008141907A (ru) Конъюгированные липидные производные
RU2013107759A (ru) Производные оксадиазола и пиридазина, их получение и применение в терапии
JP2021526552A5 (https=)
JP2024122966A (ja) 芳香族化合物およびその医薬用途
JOP20230072A1 (ar) تحضير مشتقات بنزيميدازولون كمثبطات داي أسيل جليسريد o -أسيل ترانسفيراز 2 جديدة
JPWO2019224602A5 (https=)
JOP20230071A1 (ar) تحضير مشتقات أوكسيندول كمثبطات داي أسيل جليسيريد o – أسيل ترانسفيرايز 2 جديدة
JP2008530242A5 (https=)
US11155552B2 (en) Rutaecarpine analogs and applications thereof
JP2009524686A5 (https=)
JP7508447B2 (ja) 血糖制御を改善し、炎症性腸疾患を処置するための構造修飾脂肪酸
JP5284574B2 (ja) レチノイドプロドラッグ化合物